Geron Corp. (GERN)
1.345
-0.02
(-1.82%)
USD |
NASDAQ |
Sep 11, 16:00
1.345
0.00 (0.00%)
After-Hours: 16:29
Geron Gross Profit (TTM) : 197.30M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 197.30M |
| March 31, 2026 | 190.26M |
| December 31, 2025 | 178.21M |
| September 30, 2025 | 178.25M |
| June 30, 2025 | 160.00M |
| March 31, 2025 | 112.89M |
| December 31, 2024 | 74.83M |
| September 30, 2024 | 27.86M |
| June 30, 2024 | 0.247M |
| March 31, 2024 | -0.435M |
| December 31, 2023 | -0.694M |
| September 30, 2023 | -0.602M |
| June 30, 2023 | -0.602M |
| March 31, 2023 | -0.499M |
| December 31, 2022 | -0.344M |
| September 30, 2022 | 0.596M |
| June 30, 2022 | 0.596M |
| March 31, 2022 | 0.739M |
| December 31, 2021 | 0.814M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.042M |
| September 30, 2019 | 0.042M |
| June 30, 2019 | 0.042M |
| March 31, 2019 | 0.042M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Precigen, Inc. | 76.45M |
| Editas Medicine, Inc. | 44.58M |
| Agenus, Inc. | 127.32M |
| Amgen, Inc. | 27.78B |
| Anika Therapeutics, Inc. | 75.00M |